0000000000190440

AUTHOR

A. Monnier

showing 2 related works from this author

Searches for lepton number violation and resonances in K± → πμμ decays

2017

The NA48/2 experiment at CERN collected a large sample of charged kaon decays to final states with multiple charged particles in 2003–2004. A new upper limit on the rate of the lepton number violating decay K±→π∓μ±μ± is reported: B(K±→π∓μ±μ±)<8.6×10−11 at 90% CL. Searches for two-body resonances X in K±→πμμ decays (such as heavy neutral leptons N4 and inflatons χ ) are also presented. In the absence of signals, upper limits are set on the products of branching fractions B(K±→μ±N4)B(N4→πμ) and B(K±→π±X)B(X→μ+μ−) for ranges of assumed resonance masses and lifetimes. The limits are in the (10−11,10−9) range for resonance lifetimes below 100 ps.

leptonBEAM01 natural sciences7. Clean energyPhysics Particles & FieldsHigh Energy Physics - ExperimentLIMITSkaon physicsCERNIntermediate statelepton number violation neutrinos dark matter kaon physicsPhysicsVMSMLarge Hadron ColliderPhysicsCharge KaonsneutrinosNuclear and High Energy Physics; CERN; leptonsHigh Energy Physics - Experiment; Charge Kaons; Lepton number violationNuclear & Particles PhysicsCharged particlelcsh:QC1-999NEUTRAL HEAVY-LEPTONSPhysics Nuclearlepton number violationPhysical SciencesParticle physicsNuclear and High Energy Physicsleptonskaon decays lepton number violationNuclear and High Energy Physics lepton kaon meson lepton number violation NA48Socio-culturaleAstronomy & AstrophysicsUPPER-BOUNDSdark matterNuclear physics0202 Atomic Molecular Nuclear Particle And Plasma Physics0103 physical sciencesDARK-MATTERPARTICLES010306 general physicsScience & Technologykaon decays010308 nuclear & particles physicsBranching fractionResonanceInflatonLepton numberkaon mesonNA48High Energy Physics::Experimentlcsh:PhysicsLepton
researchProduct

Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemia.

2013

Summary Concerns have recently emerged about the quality of generic vancomycin products. Our aim is to analyze serum vancomycin concentrations measured 48 hours after the start of an empirical treatment regimen in patients with acute myeloid leukemia (AML) who received one of the two generic vancomycin products available in France. Patients and methods Seventy-nine AML patients treated with vancomycin during two study periods were included in the study. Our vancomycin dosing regimen was based on the patients’ total body weight adjusted for renal clearance. Results A total of 93 serum vancomycin concentrations were collected: 31 in period 1 and 62 in period 2. In bivariate analysis, the mean…

AdultMalemedicine.medical_specialtyAdolescentPharmaceutical ScienceKidneyGastroenterologyYoung AdultVancomycinInternal medicinemedicineDrugs GenericHumansIn patientGeneric ProductAgedRetrospective StudiesPharmacologybusiness.industryMyeloid leukemiaSerum concentrationMiddle AgedAnti-Bacterial AgentsRegimenLeukemia Myeloid AcuteImmunologyVancomycinFemaleHemoglobinbusinessmedicine.drugClearanceAnnales pharmaceutiques francaises
researchProduct